Free Trial

Alaunos Therapeutics (TCRT) SEC Filings & 10K Form

Alaunos Therapeutics logo
$1.96 -0.06 (-2.97%)
(As of 12/20/2024 05:16 PM ET)

Recent Alaunos Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
8:30 AM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2024
7:30 AM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:35 PM
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Groenewald Ferdinand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
5:58 PM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 8-K/A
07/16/2024
5:58 PM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 8-K/A
07/16/2024
8:00 AM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
8:02 AM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
4:01 PM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:57 AM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:45 PM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form DEF 14A
04/26/2024
3:49 PM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form DEFA14A
04/26/2024
3:52 PM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form ARS
04/15/2024
4:23 PM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form PRE 14A
04/01/2024
6:30 AM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2024
8:46 PM
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Groenewald Ferdinand (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/22/2024
3:44 PM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
11:43 AM
Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics (Subject)
DISCOVERY CAPITAL MANAGEMENT, LLC / CT (Filed by)
Form SC 13G/A
01/29/2024
7:45 AM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
4:47 PM
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Hogue Dale Curtis Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:30 PM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
4:30 PM
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Hogue Dale Curtis Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:25 PM
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Hogue Dale Curtis Jr. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:00 AM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:30 PM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:30 PM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
7:00 AM
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TCRT) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners